Binge Eating Disorder Program
Binge Eating Disorder is a common disorder characterized by:
-Eating an extremely large amount of food within a 2-hour period (a binge) at least once a week on average for at least 3 months.
-Feeling unable to control how much you eat during a binge.
-Feeling very unhappy about binging.
If you have Binge Eating Disorder, you also have three (or more) of the following symptoms:
You eat more quickly than normal during a binge.
You eat until you are painfully full.
You binge eat when you are not hungry, to reduce stress or to comfort yourself.
You eat alone because you are embarrassed about how much food you eat.
You feel upset, guilty, or depressed after binge eating.
(from WebMD and DSM-5):
Binge Eating Disorder is thought to effect 2-5% of the population.
Dr. Young and his staff have been involved in researching this disorder for several years and have conducted clinical trials for treatment. Dr. Young and RCBM are members of the Binge Eating Disorder Association (BEDA).
In January 2015, the FDA announced that Vyvanse, lisdexamfetamine dimesylate, has been approved for the treatment of binge eating disorder. Vyvanse has been shown to decrease the number of binge episodes. Patients treated with Vyvanse reported improved quality of life. If you have concerns about binge eating disorder, the Rochester Center for Behavioral Medicine has developed a comprehensive program integrating medications and behavioral treatment. We emphasize accurate diagnosis, appropriate medications, and individualized exercise and nutritional recommendations. The program is led by Joel L Young, MD and Melissa Oleshansky, PhD.
Aliya Pasik, PA-C PA-C
Erika Samulak, MA, LPC MA, LLPC, Research Team Lead
Helene Kroll, LMSW, CAADC
Joel L. Young, MD MD
Lisa Michaux, MSN, PMHCNS-BC MSN, PMHCNS-BC
Melissa Oleshansky, PhD, LP, RYT PhD, LP, RYT
Mindy Layne Young, MSW, CSW, JD MSW, CSW, JD
Sarah Hutton, M.D.